Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.
from NYT > Health https://ift.tt/pTq5nkA
via IFTTT
from NYT > Health https://ift.tt/pTq5nkA
via IFTTT
No comments